Cystatin C and risk of new-onset depressive symptoms among individuals with a normal creatinine-based estimated glomerular filtration rate: A prospective cohort study

Authors

Li Haibin
Wang Anxin
Qi Gao
Guo Jin
Li Xia
Wei Wang, Edith Cowan UniversityFollow
Xiang Yutao
Guo Xiuhua

Document Type

Journal Article

Publication Title

Psychiatry Research

ISSN

1872-7123

Volume

273

First Page

75

Last Page

81

PubMed ID

30640054

Publisher

Elsevier / North-Holland Biomedical Press

School

School of Medical and Health Sciences / Global Health and Genomics

RAS ID

28590

Comments

This is an Author's Accepted Manuscript of: Li, H., Wang, A., Qi, G., Guo, J., Li, X., Wang, W., . . . Guo, X. (2019). Cystatin C and risk of new-onset depressive symptoms among individuals with a normal creatinine-based estimated glomerular filtration rate: A prospective cohort study. Psychiatry Research, 273, 75-81. Available here

© 2019. This manuscript version is made Available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/

Abstract

The association between cystatin C and depressive symptoms in the general population has not been thoroughly elucidated to date. We investigated the association of cystatin C with new-onset depressive symptoms among individuals with normal creatinine-based estimated glomerular filtration rates (eGFR). In the China Health and Retirement Longitudinal Study, 5111 participants without depressive symptoms or renal dysfunction (eGFR < 60 ml/min/1.73 m

DOI

10.1016/j.psychres.2019.01.009